SCHEMBL804632

SCHEMBL804632

CNc1ccc(-c2cn3c(n2)sc2cc(OCCCF)ccc23)cc1

nearest known ligand 0.90

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 5/20 0.90
LMNA P02545 2/20 0.53
TP53 P04637 2/20 0.53
MAPT P10636 2/20 0.53
TSHR P16473 1/20 0.53
RAB9A P51151 1/20 0.53
ATM Q13315 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
RXFP1 Q9HBX9 1/20 0.52
FLT3 P36888 9/20 0.50
KDR P35968 2/20 0.48
BMPR1B O00238 1/20 0.48
MUSK O15146 1/20 0.48
EPHB6 O15197 1/20 0.48
MAP3K7 O43318 1/20 0.48
RIPK2 O43353 1/20 0.48
PAK3 O75914 1/20 0.48
STK10 O94804 1/20 0.48
MAP4K4 O95819 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL772879 0.95 APP (1.00) APPLMNATP53MAPTTSHR
SCHEMBL796995 0.95 APP (1.00) APPLMNATP53MAPTTSHR
SCHEMBL10067594 0.91 APP (0.89) APPLMNATP53MAPTTSHR
SCHEMBL804634 0.91 APP (0.89) APPLMNATP53MAPTTSHR
SCHEMBL24757674 0.91 APP (0.81) APPLMNATP53MAPTTSHR
SCHEMBL805073 0.91 APP (0.85) APPLMNATP53MAPTTSHR
SCHEMBL10067623 0.90 APP (0.86) APPLMNATP53MAPTTSHR
SCHEMBL796966 0.90 APP (0.83) APPLMNATP53MAPTTSHR
SCHEMBL10067593 0.89 APP (0.82) APPLMNATP53MAPTTSHR
SCHEMBL772880 0.87 APP (0.85) APPLMNATP53MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
WO-2010092111-A2 COMPOUNDS FOR NON-INVASIVE MEASUREMENT OF AGGREGATES OF AMYLOID PEPTIDES Technische Universität München (DE) 2010-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides IAPP, APP, HTT APP 2/4885LMNA 1196/4885TP53 619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.